David J. Witter

1.6k total citations
19 papers, 1.1k citations indexed

About

David J. Witter is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, David J. Witter has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in David J. Witter's work include Histone Deacetylase Inhibitors Research (8 papers), Peptidase Inhibition and Analysis (6 papers) and Protein Degradation and Inhibitors (5 papers). David J. Witter is often cited by papers focused on Histone Deacetylase Inhibitors Research (8 papers), Peptidase Inhibition and Analysis (6 papers) and Protein Degradation and Inhibitors (5 papers). David J. Witter collaborates with scholars based in United States and Canada. David J. Witter's co-authors include Thomas A. Miller, Sandro Belvedere, John C. Vederas, Johan P. van den Heever, Karine Auclair, Andrew Sutherland, Jonathan Kennedy, C. Richard Hutchinson, Kevin J. Wilson and J. Paul Secrist and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

David J. Witter

19 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. Witter United States 16 890 411 272 255 109 19 1.1k
Fabrice Anizon France 27 1.1k 1.2× 1.3k 3.1× 200 0.7× 269 1.1× 70 0.6× 95 2.1k
Yutaka Koguchi Japan 12 620 0.7× 353 0.9× 108 0.4× 197 0.8× 38 0.3× 15 962
Michael L. Curtin United States 22 640 0.7× 633 1.5× 64 0.2× 286 1.1× 38 0.3× 40 1.2k
Dean Stamos United States 21 704 0.8× 598 1.5× 104 0.4× 209 0.8× 70 0.6× 30 1.4k
Charles G. Caldwell United States 20 428 0.5× 510 1.2× 115 0.4× 160 0.6× 46 0.4× 32 1.0k
Christoph Gaul Switzerland 21 611 0.7× 745 1.8× 226 0.8× 136 0.5× 89 0.8× 32 1.2k
Kabirul Islam United States 19 729 0.8× 444 1.1× 90 0.3× 65 0.3× 83 0.8× 47 1.1k
C. V. C. Prasad United States 18 463 0.5× 812 2.0× 149 0.5× 108 0.4× 187 1.7× 28 1.2k
Jakob Felding Denmark 20 665 0.7× 895 2.2× 250 0.9× 72 0.3× 217 2.0× 32 1.5k
Joseph S. Warmus United States 19 448 0.5× 493 1.2× 73 0.3× 113 0.4× 27 0.2× 38 962

Countries citing papers authored by David J. Witter

Since Specialization
Citations

This map shows the geographic impact of David J. Witter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Witter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Witter more than expected).

Fields of papers citing papers by David J. Witter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Witter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Witter. The network helps show where David J. Witter may publish in the future.

Co-authorship network of co-authors of David J. Witter

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Witter. A scholar is included among the top collaborators of David J. Witter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Witter. David J. Witter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Heidebrecht, Richard W., Mélissa Chénard, William K. Dahlberg, et al.. (2009). Exploring the pharmacokinetic properties of phosphorus-containing selective HDAC 1 and 2 inhibitors (SHI-1:2). Bioorganic & Medicinal Chemistry Letters. 19(7). 2053–2058. 17 indexed citations
2.
Grimm, Jonathan B., Kevin J. Wilson, & David J. Witter. (2009). A Divergent Approach to the Synthesis of 3-Substituted-2-pyrazolines: Suzuki Cross-Coupling of 3-Sulfonyloxy-2-pyrazolines. The Journal of Organic Chemistry. 74(16). 6390–6393. 20 indexed citations
3.
Wilson, Kevin J., David J. Witter, Jonathan B. Grimm, et al.. (2008). Phenylglycine and phenylalanine derivatives as potent and selective HDAC1 inhibitors (SHI-1). Bioorganic & Medicinal Chemistry Letters. 18(6). 1859–1863. 20 indexed citations
4.
Witter, David J., Sandro Belvedere, Liqiang Chen, et al.. (2007). Benzo[b]thiophene-based histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(16). 4562–4567. 31 indexed citations
5.
Siliphaivanh, Phieng, Paul E. Harrington, David J. Witter, et al.. (2007). Design of novel histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(16). 4619–4624. 36 indexed citations
6.
Belvedere, Sandro, David J. Witter, Jiaming Yan, et al.. (2007). Aminosuberoyl hydroxamic acids (ASHAs): A potent new class of HDAC inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(14). 3969–3971. 30 indexed citations
7.
Witter, David J., Paul E. Harrington, Kevin J. Wilson, et al.. (2007). Optimization of biaryl Selective HDAC1&2 Inhibitors (SHI-1:2). Bioorganic & Medicinal Chemistry Letters. 18(2). 726–731. 80 indexed citations
8.
Grimm, Jonathan B., Kevin J. Wilson, & David J. Witter. (2007). Suppression of racemization in the carbonylation of amino acid-derived aryl triflates. Tetrahedron Letters. 48(26). 4509–4513. 13 indexed citations
9.
Grimm, Jonathan B., Matthew H. Katcher, David J. Witter, & Alan B. Northrup. (2007). A New Strategy for the Synthesis of Benzylic Sulfonamides:  Palladium-Catalyzed Arylation and Sulfonamide Metathesis. The Journal of Organic Chemistry. 72(21). 8135–8138. 26 indexed citations
10.
Miller, Thomas A., David J. Witter, & Sandro Belvedere. (2004). Histone Deacetylase Inhibitors. ChemInform. 35(8). 14 indexed citations
11.
Miller, Thomas A., David J. Witter, & Sandro Belvedere. (2003). Histone Deacetylase Inhibitors. Journal of Medicinal Chemistry. 46(24). 5097–5116. 468 indexed citations
12.
Auclair, Karine, Andrew Sutherland, Jonathan Kennedy, et al.. (2000). Lovastatin Nonaketide Synthase Catalyzes an Intramolecular Diels−Alder Reaction of a Substrate Analogue. Journal of the American Chemical Society. 122(46). 11519–11520. 190 indexed citations
13.
Campbell, Robert M., W. Chen, Yong Chen, et al.. (1999). Selective A1-adenosine receptor antagonists identified using yeast Saccharomyces cerevisiae functional assays. Bioorganic & Medicinal Chemistry Letters. 9(16). 2413–2418. 30 indexed citations
14.
Witter, David J., et al.. (1998). Design and synthesis of SH3 domain binding ligands: Modifications of the consensus sequence XPpXP. Bioorganic & Medicinal Chemistry Letters. 8(22). 3137–3142. 29 indexed citations
15.
Witter, David J. & John C. Vederas. (1996). Putative Diels−Alder-Catalyzed Cyclization during the Biosynthesis of Lovastatin. The Journal of Organic Chemistry. 61(8). 2613–2623. 49 indexed citations
16.
17.
Witter, David J. & C. Dale Poulter. (1996). Yeast Geranylgeranyltransferase Type-II:  Steady State Kinetic Studies of the Recombinant Enzyme. Biochemistry. 35(32). 10454–10463. 17 indexed citations
18.
Yoshizawa, Yuko, David J. Witter, Yaoquan Liu, & John C. Vederas. (1994). Revision of the biosynthetic origin of oxygens in mevinolin (lovastatin), a hypocholesterolemic drug from Aspergillus terreus MF 4845. Journal of the American Chemical Society. 116(6). 2693–2694. 36 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabrice Anizon Breakdown of academic impact, for papers by Yutaka Koguchi Breakdown of academic impact, for papers by Michael L. Curtin Breakdown of academic impact, for papers by Dean Stamos Breakdown of academic impact, for papers by Charles G. Caldwell Breakdown of academic impact, for papers by Christoph Gaul Breakdown of academic impact, for papers by Kabirul Islam Breakdown of academic impact, for papers by C. V. C. Prasad Breakdown of academic impact, for papers by Jakob Felding Breakdown of academic impact, for papers by Joseph S. Warmus
Rankless by CCL
2026